Skip to main content

M. Nicholas Burke, MD

Review
04/01/2023
Journal of Invasive Cardiology
Original Contribution
09/01/2021
Dr. Nikolakopoulos, et al. compared the clinical, angiographic, and procedural characteristics of 120 CTO-PCIs performed via dRA access with 2625 CTO-PCIs performed via proximal radial access (pRA) in a large, multicenter registry.
Dr. Nikolakopoulos, et al. compared the clinical, angiographic, and procedural characteristics of 120 CTO-PCIs performed via dRA access with 2625 CTO-PCIs performed via proximal radial access (pRA) in a large, multicenter registry.
Dr. Nikolakopoulos, et al....
09/01/2021
Journal of Invasive Cardiology
Original Contribution
07/15/2017
Outcomes with use of lesion-modification strategies in the drug-eluting stent era have received limited study. We conducted a meta-analysis of 22 studies published between 2004-2016 reporting outcomes after use of rotational atherectomy,...
Outcomes with use of lesion-modification strategies in the drug-eluting stent era have received limited study. We conducted a meta-analysis of 22 studies published between 2004-2016 reporting outcomes after use of rotational atherectomy,...
Outcomes with use of...
07/15/2017
Journal of Invasive Cardiology
Original Contribution
05/16/2023
Coronary artery dissection is a feared and potentially life-threatening complication of percutaneous coronary intervention (PCI). We examined the clinical, angiographic, and procedural characteristics, and outcomes of coronary dissection at a...
Coronary artery dissection is a feared and potentially life-threatening complication of percutaneous coronary intervention (PCI). We examined the clinical, angiographic, and procedural characteristics, and outcomes of coronary dissection at a...
Coronary artery dissection is a...
05/16/2023
Journal of Invasive Cardiology
Brief Contribution
12/01/2021
Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...
Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...
Currently only the peripheral...
12/01/2021
Journal of Invasive Cardiology
Original Contribution
09/13/2023
There is limited information on the impact of the target vessel on the procedural techniques and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We analyzed the baseline clinical and angiographic...
There is limited information on the impact of the target vessel on the procedural techniques and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We analyzed the baseline clinical and angiographic...
There is limited information on...
09/13/2023
Journal of Invasive Cardiology
Original Contribution
03/01/2023
Journal of Invasive Cardiology
Case Report
08/30/2023
Percutaneous coronary intervention (PCI) on heavily calcified lesions has been associated with more complications.1 Intravascular lithotripsy (IVL) was recently approved for treating de novo calcified coronary lesions based on excellent...
Percutaneous coronary intervention (PCI) on heavily calcified lesions has been associated with more complications.1 Intravascular lithotripsy (IVL) was recently approved for treating de novo calcified coronary lesions based on excellent...
Percutaneous coronary...
08/30/2023
Journal of Invasive Cardiology